DOC — Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• FFO (Funds From Operations): Reported at $0.46 per share.
• Net Debt-to-EBITDA: Improved to 4.7x, indicating a strong balance sheet.
• Total Occupancy: Increased by 20 basis points to 90.7%.
• Cash Re-leasing Spreads: Achieved 5%, consistent with historical averages.
• Senior Housing Performance: Same-store portfolio occupancy grew by 260 basis points, with 19% NOI growth.
• Acquisitions: Closed $1.8 billion in acquisitions since January 1, 2026.

2. Strategic Updates and Business Highlights

• Merger and IPO: Healthpeak has successfully executed a $5 billion merger and a $1 billion IPO, enhancing its scale and capabilities.
• Joint Ventures: Formed partnerships with Blackstone and Brookfield, allowing for strategic growth in outpatient medical and life science sectors.
• Agentic Operating Platform: Rollout of a new operating platform aimed at improving operational efficiency and tenant relationships.
• Outpatient Development Projects: Funding for highly pre-leased outpatient projects, including a new development in Atlanta.

3. Forward Guidance and Outlook

• FFO Guidance: Raised to a range of $1.73 to $1.77 per share, driven by improved same-store NOI.
• Growth Expectations: Anticipate continued internal growth in outpatient portfolios, with an acceleration expected in 2027.
• Acquisition Strategy: Focus on life science acquisitions, with an emphasis on capturing market share and leveraging a strong balance sheet.

4. Bad News, Challenges, or Points of Concern

• Declining Metrics: Cash re-leasing spreads showed a slight deceleration compared to previous quarters, raising concerns about potential market saturation.
• Competitive Pressures: The lab market is experiencing increased competition, particularly in pricing and tenant concessions, which may impact margins.
• Market Volatility: The potential for lumpiness in leasing activity and occupancy rates due to market conditions and tenant behaviors.
• Economic Environment: Elevated borrowing costs and market uncertainties could pose risks to capital allocation and growth strategies.

5. Notable Q&A Insights

• Lab Portfolio Outlook: Management is optimistic about occupancy improvements, but acknowledges that the timing of inflections in same-store performance remains uncertain.
• Tenant Demand: Strong demand for lab space, particularly from biotech firms, is driving leasing activity, with a notable increase in smaller tenants.
• CapEx Expectations: Generally low capital costs for second-generation leases, with an average of 10% for renewals and 20-25% for new leasing.
• Market Dynamics: The Bay Area and San Diego are highlighted as strong demand markets, while Boston faces challenges due to supply overhang.
• Future Acquisitions: Management is focused on core markets and is open to both fee simple acquisitions and structured finance deals, depending on market conditions.

Overall, Healthpeak Properties demonstrated solid financial performance in Q2 2026, with strategic initiatives positioning the company for future growth despite facing some competitive and market challenges.